← Back to Clinical Trials
Recruiting NCT07372547

NCT07372547 Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07372547
Status Recruiting
Phase
Sponsor Assuta Ashdod Hospital
Condition Post-void Residual Volume
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-01-20
Primary Completion 2028-01-20

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Voiding position - Standing in the showerVoiding position - Sitting on the toilet

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-01-20 with a primary completion date of 2028-01-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if voiding in a standing position in the shower, rather than sitting on a toilet, may reduce pain associated with the act of voiding, thereby facilitating micturition and decreasing both post-void residual volume and the risk of subsequent urinary retention in women that underwent benign vaginal surgeries.

Eligibility Criteria

Inclusion Criteria: * Adult women (≥18 years old). * Undergoing benign vaginal gynecologic surgery with indwelling catheter during surgery. * No bladder injury during surgery. * Ability and willingness to consent. * No known neurological or urinary conditions affecting voiding. * No active urinary tract infection at time of catheter removal. Exclusion Criteria: * Bladder injury during surgery. * Neurological disease affecting bladder function. * Active urinary tract infection. * Inability to void either standing in shower or sitting (depending on randomization).

Contact & Investigator

Central Contact

Elad Preuss, M.D

✉ eladp@assuta.co.il

📞 +072545228700

Frequently Asked Questions

Who can join the NCT07372547 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 99 Years, studying Post-void Residual Volume. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07372547 currently recruiting?

Yes, NCT07372547 is actively recruiting participants. Contact the research team at eladp@assuta.co.il for enrollment information.

Where is the NCT07372547 trial being conducted?

This trial is being conducted at Ashdod, Israel, Ashdod, Israel.

Who is sponsoring the NCT07372547 clinical trial?

NCT07372547 is sponsored by Assuta Ashdod Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology